Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas.
Isocitrate dehydrogenase 1 gene mutations are found in most World Health Organization grade II and III gliomas and secondary glioblastomas. Isocitrate dehydrogenase 1 mutations are known to have prognostic value in high-grade gliomas. However, their prognostic significance in low-grade gliomas remai...
Main Authors: | Ming-Yang Li, Yin-Yan Wang, Jin-Quan Cai, Chuan-Bao Zhang, Kuan-Yu Wang, Wen Cheng, Yan-Wei Liu, Wei Zhang, Tao Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4482584?pdf=render |
Similar Items
-
Clinico-neuropathological features of isocitrate dehydrogenase 2 gene mutations in lower-grade gliomas
by: Lei-Ming Wang, et al.
Published: (2019-12-01) -
Screening of Methylation Signature and Gene Functions Associated With the Subtypes of Isocitrate Dehydrogenase-Mutation Gliomas
by: XiaoYong Pan, et al.
Published: (2019-11-01) -
Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical Indications
by: Yang Liu, et al.
Published: (2020-08-01) -
Isocitrate dehydrogenase 1 and 2 genes mutations and MGMT methylation in gliomas
by: D. V. Tabakov, et al.
Published: (2017-04-01) -
Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development
by: Juan Huang, et al.
Published: (2019-06-01)